Advances in Hidradenitis Suppurativa

Multimedia Medical Education

Supported by an educational grant from AbbVie.*
Medical accuracy confirmed at release date.

Modifying the Impact of HS: Lifestyle Considerations
from Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa
EADV 2018
Thrasyvoulos Tzellos, MD, MSc, PhD
Release Date: 15 October 2018
Addressing the Psychosocial Symptoms of HS
from Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa
EADV 2018
Errol P. Prens, MD, PhD
Release Date: 15 October 2018
Easing the Pain: Approaches for Clinicians Managing HS
from Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa
EADV 2018
Falk G. Bechara, MD
Release Date: 15 October 2018
What’s the Goal? Perspectives on What We Want to Achieve for Patients With HS
from Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa
EADV 2018
Errol P. Prens, MD, PhD
Release Date: 15 October 2018

Faculty Communications

Case Studies, Literature Reviews, and Survey Results

Highlights from the 6th EHSF Conference in 2017
Kelsey R. van Straalen, MD
Hessel H van der Zee, MD

Join the Discussion
Survey Report: How Do Clinicians Approach the Management of Hidradenitis Suppurativa?
Caitriona Ryan, MD

Join the Discussion
Literature Review: Evaluating the Psychological Burden of HS and Its Impact on Relationships and Sexual Function
Hessel H van der Zee, MD, PhD

Join the Discussion

Patient Case Studies

seven-year-old child with classical presentation of PLS with both dermatological and dental findings. He first presented...

51-year old male patient was treated with adalimumab due to psoriasis arthritis. About 18 months after treatment initiation,...

19-year-old girl who had a history of pulmonary TB 10 years ago. Assessment of her immune condition ruled out any immunodeficiency...

See more >>

In the News

AAD Releases First-Ever Guidelines for Treating Paediatric Patients With Psoriasis
The American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) have released guidelines to help ensure that paediatric psoriasis patients receive the best possible treatment and care. The joint AAD/NPF guidelines, published in the Journal of the American Academy of...
Psoriasis Appears Associated With Increased Risk of Developing, Dying of Cancer
Patients with psoriasis appear to have an increased risk of cancer incidence and cancer-related mortality, according to a study published in JAMA Dermatology. For the study, Alex Trafford, University of Manchester, Manchester, United Kingdom, and colleagues searched through 6 electronic databases...
Imaging Tests Help Reveal Heart Risks in Patients With Psoriatic Disease
Combining vascular imaging data with information on cardiovascular risk factors may improve the accuracy of cardiovascular risk stratification in patients with psoriatic disease, according to a study published in Arthritis...
See more >>

Conference Reports

Risankizumab Bests Fumaric Acid Esters for Treatment-Naïve Patients With Plaque Psoriasis in Head-to-Head Trial

By Eric Ramos

MADRID, Spain -- October 13, 2019 -- A head-to-head trial comparing risankizumab (Skyrizi) with oral fumaric acid esters (FAE) for treatment-naïve patients with moderate-to-severe plaque psoriasis has demonstrated the superiority of risankizumab for all studied efficacy...

Higher Systemic Exposure to Crisaborole of Children Versus Adults With Psoriasis Is Unlikely

By Brian Hoyle

CHICAGO -- September 18, 2019 -- The likelihood of children with psoriasis having a higher systemic exposure to crisaborole than adults after topical application is low, according to a study presented here at the 2019 Annual Meeting of the American College of Clinical...

Risankizumab More Effective, Durable Than Ustekinumab in Moderate-to-Severe Psoriasis

By Marielle Fares, PharmD

Washington, DC -- March 8, 2019 -- In patients with moderate-to-severe psoriasis, risankizumab shows superior efficacy to ustekinumab after 52 weeks of treatment, according to an integrated analysis of the phase 3 UltlMMa-1 and UltlMMa-2 trials presented here at...

see more >>

Recently Published

Pustular psoriasis and related pustular skin diseases
H Bachelez
Differences in staining for neutrophil elastase and its controlling inhibitor SLPI reveal heterogeneity among neutrophils in psoriasis
Joanna Skrzeczynska-Moncznik, Katarzyna Zabieglo, Oktawia Osiecka, Agnieszka Morytko, Piotr Brzoza, Lukasz Drozdz, Monika Kapinska-Mrowiecka, Brice Korkmaz, Maciej Pastuszczak, Joanna Kosalka-Wegiel, Jacek Musial, Joanna Cichy
Visceral Adiposity in Psoriasis is Associated With Vascular Inflammation by 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Beyond Cardiometabolic Disease Risk Factors in an Observational Cohort Study
Joshua P Rivers, Tiffany M Powell-Wiley, Amit K Dey, Justin A Rodante, Jonathan H Chung, Aditya A Joshi, Balaji Natarajan, Aparna P Sajja, Abhishek Chaturvedi, Anshuma Rana, Charlotte L Harrington, Heather L Teague, Benjamin N Lockshin, Mark A Ahlman, Jianhua Yao, Martin P Playford, Joel M Gelfand, Nehal N Mehta
See more >>

Full-Text Articles

BMJ Open
Impact of red and processed meat and fibre intake on treatment outcomes among patients with chronic inflammatory diseases: protocol for a prospective cohort study of prognostic factors and personalised medicine
Robin Christensen, Berit L Heitmann, Karina Winther Andersen, Ole Haagen Nielsen, Signe Bek Sørensen, Mohamad Jawhara, Anette Bygum, Lone Hvid, Jakob Grauslund, Jimmi Wied, Henning Glerup, Ulrich Fredberg, Jan Alexander Villadsen, Søren Geill Kjær, Jan Fallingborg, Seyed A G R Moghadd, Torben Knudsen, Jacob Brodersen, Jesper Frøjk, Jens Frederik Dahlerup, Anders Bo Bojesen, Grith Lykke Sorensen, Steffen Thiel, Nils J Færgeman, Ivan Brandslund, Tue Bjerg Bennike, Allan Stensballe, Erik Berg Schmidt, Andre Franke, David Ellinghaus, Philip Rosenstiel, Jeroen Raes, Mette Boye, Lars Werner, Charlotte Lindgaard Nielsen, Heidi Lausten Munk, Anders Bathum Nexøe, Torkell Ellingsen, Uffe Holmskov, Jens Kjeldsen, Vibeke Andersen
Acta Dermato-Venereologica
Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort Study
Juul M P A van den Reek, Lieke J van Vugt, Martijn B A van Doorn, Gayle E van der Kraaij, Wim J A de Kort, Georges P H Lucker, Barbara Horvath, M David Njoo, H Jorn Bovenschen, Paul M Ossenkoppele, Marjolein S de Bruin-Weller, Marjan de Groot, Roland Mommers, Ruud L M A Prevoo, Peter C M van de Kerkhof, Phyllis I Spuls, Wietske Kievit, Elke M G J de Jong
Journal of Peking University. Health Sciences (Beijing Da Xue Xue Bao. Yi Xue Ban)
[Cross-sectional study on clinic behavior and therapeutic status of patients with psoriatic arthritis in multi-center]
Y H Li, B Su, F A Lin, Y N Fei, X X Yu, W Q Fan, H Y Chen, X W Zhang, Y Jia
See more >>

Hessel H van der Zee, MD, PhD and Caitriona Ryan, MD, invite you to explore the education and resources on this site, designed to provide a comprehensive approach to managing patients with hidradenitis suppurativa.

Hessel H van der Zee, MD, PhD
Erasmus University Medical Center
Rotterdam, the Netherlands

Caitriona Ryan, MD
St. Vincent's Hospital
Dublin, Ireland


User-friendly learning modules available in short and accessible formats.

Insights and developments in HS from leading experts.

Continuously updated news and conference coverage.

Helpful resources for your practice and patients.